UK Innovation & Science Seed Fund News

In 2010, UKI2S made a £25,000 pathfinder investment in Tokamak Energy, a spin-out from the Culham Centre for Fusion Energy, to support the commercial development of a fusion neutron device. Tokamak today announces that it has reached a major milestone, reaching 100 million °C, substantiating the use of spherical tokamaks as the optimal route to […]

read more

Coventry, United Kingdom, 10th March 2022 / Sciad Newswire / NanoSyrinx, a biotech company using synthetic biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics, has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer. Dr McAvoy joins NanoSyrinx from GSK where she was Senior Director in […]

read more

Oxford, UK, 1 March 2022 / HydRegen, the revolutionary bioscience company, enables sustainable chemical manufacturing using their proprietary enzyme based redox platform. The company has received £385,000 in new funding from the UK Innovation & Science Seed Fund (UKI2S), alongside private investors, to work in collaboration with pharmaceutical and fine chemical companies that want to […]

read more

1 2 3 4 44